PharmiWeb.com - Global Pharma News & Resources
20-Jan-2023

Glaucoma Surgery Devices Market Share Growth, Size Value, Trends, Regional Outlook 2023 to 2032 | insightSLICE

A collection of conditions known as glaucoma that damage the optic nerve and cause vision loss are typically distinguished by elevated intraocular pressure (IOP). With the aid of glaucoma surgery equipment, ocular pressure can be reduced to either avoid or lessen damage to the optic nerve.

Access the sample report: https://www.insightslice.com/request-sample/1161

Market status for Glaucoma surgery devices:

The market estimates in the Glaucoma Surgery Devices market research report cover the years 2019 to 2032. Throughout the projection period, the market expansion is anticipated to be aided by the increasing worldwide burden of glaucoma.

Expanding the patient population and upgrading health services are anticipated to boost demand for surgery instruments and propel the market forward.

The market for this surgical equipment is also anticipated to be driven by government support, particularly in developing countries, in the form of advantageous healthcare expenditure and foreign direct investment provisions.

Over the forecast timeframe, increasing demand for minimally invasive glaucoma surgery (MIGS) operations is expected to increase the need for sophisticated glaucoma surgery devices.

The demand for MIGS treatments and equipment is rising as a result of advantages like faster healing times, more affordable costs, and a lower risk of post-operative problems such as hypotony.

The key players of the Global Glaucoma Surgery Devices Market are:

Geuder AG Company, Camras Vision Company, Meir Medical Center Company, Anteis SA Company, Eye Sonix Company, Ellex Medical Lasers Ltd., Medtronic PLC Company, Ocumatrx Company, and others are significant market participants in the worldwide glaucoma surgery devices market.

Read more about the report inclusions: https://www.insightslice.com/glaucoma-surgery-devices-market

Factors affecting growth:

Patients are increasingly choosing permanent surgical treatments over long-term medication therapy in recent times. According to their stage of glaucoma, glaucoma patients typically take a variety of drugs, which leads to a lot of problems with patient adherence.

The patients’ pharmaceutical load is greatly reduced after glaucoma surgery. Furthermore, issues with medication’s therapeutic effectiveness, such as poor bioavailability, treatment failure, and cytotoxicity, have increased sales for surgical methods and technologies, which has helped the market expand.

The expansion of glaucoma treatment programs is being carried out through several organization in governmental and NGO settings which is anticipated to positively affect the uptake of latest technologies and instruments.

Such initiatives for mass surgery and eye exams also raise awareness and help raise money for medical supplies and equipment in long run. These programs have decreased the number of glaucoma patients that go untreated, which has increased sales for glaucoma treatment methods and equipment.

Impact of the pandemic:

Processes in the medical community have been hampered by the COVID-19 epidemic in different parts of the world. A number of companies, including some parts of the healthcare industry, have been compelled to temporarily close their doors as a result of the sickness.

Additionally, there has been a detrimental impact on a number of services, particularly glaucoma surgery equipment. Additionally, there has been a considerable decrease in clinical visits to doctors as a result of the COVID-19 outbreak.

As a result, fewer elective eye procedures are being performed every week in clinics and hospitals. The COVID-19 pandemic had a significant impact on the operation of hospital emergency treatment for patients who did not have COVID-19 infection in hospitals around the world.

Demand for glaucoma surgery devices is anticipated to be dampened in the near future as many clinics and hospitals continue to be shuttered as a result of lockdowns.

Global Glaucoma Surgery Devices Market Key Segments:

By Product Type

  • Ultrasound Equipment
  • Laser Equipment
  • Other

By Application

  • Hospital
  • Physical Examination Center
  • Other

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Proceed to purchase: https://www.insightslice.com/buy-now/1161

Market segments and their performance:

According to surgery type, the traditional glaucoma surgeries segment led the worldwide glaucoma surgery device market in 2020 and is anticipated to maintain its position throughout the forecast period.

This is due to factors like an increase in intracranial pressure reduction performance and mainstream glaucoma surgery’s low treatment costs, as well as the use of traditional glaucoma surgery as the first line of treatment in developing economies because it is less expensive than MIG.

In 2020, the implants & stents category led the market for glaucoma surgery equipment worldwide. Even during the forecast timeframe, this dominance is likely to persist. Due to their use in glaucoma surgery to lower intraocular pressure and promote intraocular fluid circulation, implantation and stents are in greater demand.

Due to increased glaucoma surgical device adoption, the accessibility of eye surgeons, and increased focus and spending on vision care by eye clinics and ophthalmology clinics, the portion of eye hospitals and ophthalmology clinics held the highest market share in 2020 and is anticipated to maintain its dominant position during the forecast period.

Due to improvements in the healthcare system, an increase in expendable cash, the established existence of domestic businesses in the region, the accessibility of glaucoma surgery devices, a huge influx in healthcare legislation, and advancements in the field of health insurance, Asia-Pacific presents profitable positions for major players operating in the glaucoma surgery devices market, thus further registering the best rate of growth during the forecast period.

Major manufacturers have also been concentrating on increasing their geographic reach in developing Asia-Pacific nations to take advantage of possible growth prospects in the market for glaucoma surgery devices.

Related reports:

Global Non-Steroidal Anti-Inflammatory Drugs Market: https://www.insightslice.com/non-steroidal-anti-inflammatory-drugs-market

Global Digestive Enzymes Market: https://www.insightslice.com/digestive-enzymes-market

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.

Contact us:

Alex R

+1 707 736 6633

alex@insightslice.com

https://www.insightslice.com/

Linkedin | Twitter

Editor Details

Last Updated: 20-Jan-2023